From: Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection
Samples | N = 1 | N = 2 | N = 3 | Mean ± SEM | P value | |
---|---|---|---|---|---|---|
IC50 (nM) | IC50 (nM) | IC50 (nM) | vs S-Insulin | Lantus Vs. Lisargine | ||
S-Insulin | 0.98 | 0.83 | 0.42 | 0.58 ± 0.09 | / | / |
Lantus | 0.58 | 0.50 | 0.42 | 0.45 ± 0.02 | 0.228 | / |
H-Insulin | 0.69 | 0.51 | 0.45 | 0.51 ± 0.04 | 0.342 | / |
Lisargine | 1.04 | 0.76 | 0.55 | 0.70 ± 0.08 | 0.861 | 0.129 |